文献速递心境障碍会诊联络精神医学

多重用药与共病抑郁和2型糖尿病患者的抑郁复发关联

Association between polypharmacy and depression relapse in individuals with comorbid depression and type 2 diabetes: a UK electronic health record study.
PubMed 文献 · Br J Psychiatry · 2023-01-01

停用后1年内35%重新用药提示复发;多重用药至最多18种并发药物时重新用药风险为HR=2.15(95%CI 1.32-3.51),既往抗抑郁治疗≥25个月者风险为HR=2.36(95%CI 2.25-2.48),二者无交互作用。

要点

  • 停用抗抑郁药后1年内35%重新用药,提示抑郁复发。
  • 多重用药至18种时重新用药风险HR=2.15(95%CI 1.32-3.51)。
  • 既往治疗≥25个月者重新用药风险HR=2.36(95%CI 2.25-2.48)。

核心结论

  • 多重用药和较长既往抗抑郁治疗时长可能与停用抗抑郁药后的抑郁复发相关。

主要发现

  • 停用抗抑郁药后1年内35%的参与者重新用药,提示抑郁复发。
  • 随着多重用药增加,重新用药率上升,至最多18种并发药物时重新用药可能性超过两倍(HR=2.15,95%CI 1.32-3.51)。
  • 随着既往抗抑郁治疗时长增加,重新用药率上升,既往时长≥25个月者重新用药可能性超过两倍于既往<7个月者(HR=2.36,95%CI 2.25-2.48)。
  • 未发现多重用药与既往抗抑郁治疗时长之间存在交互作用。

临床怎么用

  • 对共病抑郁与2型糖尿病且多重用药者,停用抗抑郁药后应加强复发监测。
  • 对既往抗抑郁治疗时长较长者,停用抗抑郁药后应关注抑郁复发风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Individuals with physical comorbidities and polypharmacy may be at higher risk of depression relapse, however, they are not included in the 'high risk of relapse' group for whom longer antidepressant treatment durations are recommended. AIMS: In individuals with comorbid depression and type 2 diabetes (T2DM), we aimed to investigate the association and interaction between depression relapse and (a) polypharmacy, (b) previous duration of antidepressant treatment. METHOD: This was a cohort study using primary care data from the UK Clinical Practice Research Datalink (CPRD) from years 2000 to 2018. We used Cox regression models with penalised B-splines to describe the association between restarting antidepressants and our two exposures. RESULTS: We identified 48 001 individuals with comorbid depression and T2DM, who started and discontinued antidepressant treatment during follow-up. Within 1 year of antidepressant discontinuation, 35% of participants restarted treatment indicating depression relapse. As polypharmacy increased, the rate of restarting antidepressants increased until a maximum of 18 concurrent medications, where individuals were more than twice as likely to restart antidepressants (hazard ratio (HR) = 2.15, 95% CI 1.32-3.51). As the duration of previous antidepressant treatment increased, the rate of restarting antidepressants increased - individuals with a previous duration of ≥25 months were more than twice as likely to restart antidepressants than those who previously discontinued in <7 months (HR = 2.36, 95% CI 2.25-2.48). We found no interaction between polypharmacy and previous antidepressant duration. CONCLUSIONS: Polypharmacy and longer durations of previous antidepressant treatment may be associated with depression relapse following the discontinuation of antidepressant treatment.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Jeffery A, Bhanu C, Walters K, et al. Association between polypharmacy and depression relapse in individuals with comorbid depression and type 2 diabetes: a UK electronic health record study. Br J Psychiatry. 2023. PMID: 36451601. doi:10.1192/bjp.2022.160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。